HOME
SEARCH
RSS FEED
SUBSCRIBE
Search Results - signaling
3
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Novel ACRV1/ALK2 Inhibitors and Methods for Inhibiting BMP
Signaling
for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)
This technology includes the identification and use of novel ACRV1/ALK2 inhibitors for the treatment of fibrodysplasia ossificans progressiva (FOP), an autosomal-dominant rare disease that affects one person in every 1-2 million. FOP is characterized by malformation of the great (big) toes during embryonic development and by progressive heterotopic...
Published: 10/28/2024
|
Inventor(s):
Jian-kang Jiang
,
Khalida Shamim
,
Philip Sanderson
,
Wei Zheng
,
Xiuli Huang
,
Gregory Tawa
,
Asaf Alimardanov
,
Arthur Lee
,
Junfeng Huang
,
Wenwei Huang
Keywords(s):
ALK2
,
BMP
,
INHIBITING
,
Inhibitors
,
Methods
,
Novel
,
SIGNALING
,
VGXXXX
,
WIXXXX
,
WKXXXX
,
XEXXXX
Category(s):
TherapeuticArea > Endocrinology
,
Application > Therapeutics
,
Application > Research Materials
Antagonists of Hyaluronan
Signaling
for Treatment of Airway Diseases
Airway diseases, such as Asthma and Chronic Obstructive Pulmonary Disease (COPD), constitute a major health burden worldwide. It is estimated, for example, that nearly 15.0% of the adult population in the US are affected with such diseases, and the economic cost burden is over $23 billion annually. Unfortunately, the current options for treatment of...
Published: 10/28/2024
|
Inventor(s):
John Hollingsworth
,
Bryan Toole
,
Jian Liu
,
Stavros Garantziotis
Keywords(s):
AIRWAY
,
ANTAGONISTS
,
hyaluronan
,
Hyperresponsiveness
,
IB4XXX
,
IBXXXX
,
Inflammation
,
IXXXXX
,
SIGNALING
,
treatment
,
VPXXXX
,
WKXXXX
,
YBXXXX
,
YCXXXX
Category(s):
Collaboration Sought > Collaboration
,
TherapeuticArea > Ophthalmology
,
Application > Therapeutics
,
TherapeuticArea > Endocrinology
,
TherapeuticArea > Oncology
,
TherapeuticArea > Dental
,
Application > Diagnostics
,
Application > Research Materials
,
TherapeuticArea > Cardiology
,
TherapeuticArea > Infectious Disease
,
TherapeuticArea > Pulmonology
Transgenic Mice with Conditionally-Enhanced Bone Morphogen Protein (BMP)
Signaling
: A Model for Human Bone Diseases
This technology relates to novel animal models of several human bone diseases that have been linked to enhanced BMP
signaling
. More specifically, this mouse model expresses a mutant receptor for BMP, known as Alk2 that is always actively signaling. This receptor is under the control of the Cre-loxP system, which allows control of expression of the...
Published: 10/28/2024
|
Inventor(s):
Manas Ray
,
Gregory Scott
,
Yuji Mishina
Keywords(s):
BAXXXX
,
BMP:
,
Bone
,
Craniosynostosis
,
Disease
,
Enhanced
,
Expressing
,
Fibrodysplasia ossificans progressiva
,
Human
,
IDXXXX
,
IXXXXX
,
Model
,
MORPHOGENETIC
,
Mouse
,
MULTIPLE MYELOMA
,
Protein
,
SIGNALING
Category(s):
Collaboration Sought > Licensing
,
Application > Therapeutics
,
ResearchProducts > Animal Models
,
Application > Diagnostics
,
Application > Research Materials
Home
|
Search
|
RSS
|
Subscribe
© 2025. All Rights Reserved. Powered by
Inteum